Allenex AB: Nasdaq Stockholm Has Approved Application for De-Listing

Regulatory News:

Allenex (STO:ALNX)

Allenex AB (publ) announced on 20 May 2016 that the company had decided to apply for de-listing of the Allenex share from Nasdaq Stockholm. The application has now been approved.

The last day of trading in the Allenex share will be Wednesday 8 June 2016.

Allenex AB discloses the information provided herein pursuant to the Securities Markets Act and /or the Financial Instruments Trading Act. The information was submitted for publication on May 25, 2016, at 08.00 CET. Allenex is a life science-company that develops, manufacture, market and sell products for safer transplants of organs and bone marrow on the global market. Allenex is listed on NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 57 persons are employed in the Allenex group.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160524006794/en/